Defining the clinical course of multiple sclerosisFred Lublin, Chris H. Polman, Stephen C. Reingold et al.|Neurology|2014Cited by 3.1k
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosisXavier Montalbán, Frauke Zipp, Ralf Gold et al.|Multiple Sclerosis Journal|2018Cited by 706
Multiple sclerosis progression: time for a new mechanism-driven frameworkTanja Kuhlmann, Emmaunelle Waubant, Marcello Moccia et al.|The Lancet Neurology|2022Cited by 624
MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic processXavier Montalbán, Àlex Rovira, Mike P. Wattjes et al.|Nature Reviews Neurology|2015Cited by 423
Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical EventDarin T. Okuda, Christine Lebrun‐Frénay, Aksel Sıva et al.|PLoS ONE|2014Cited by 332